State health officials are recommending preventive child immunizations to prevent respiratory viruses in infants and young ...

RSV can present as mild, cold-like symptoms in many children, but it is the leading cause of hospitalization in babies under 1 year, and can lead to conditions like pneumonia and bronchiolitis. While ...

Credit: Getty Images. The BLA acceptance was supported by data from the randomized, placebo-controlled phase 2b/3 CLEVER trial as well as interim data from the ongoing phase 3 SMART trial. A ...

Credit: Merck Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody that is designed to provide durable protection through 5 months. The ACIP voted that Enflonsia ...

Respiratory syncytial virus, a common illness that can resemble a cold, is still sending infants to the hospital at higher ...

New prevention measures for RSV, a respiratory virus that can be especially harmful to babies, became widely available this past winter. The new measures include a vaccine given in pregnancy and ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the monoclonal antibody clesrovimab-cfor for preventing RSV disease in babies. Unlike ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all their hospitalizations. However, a study published in Morbidity and Mortality ...

Adults aged 18 to 49 years at increased risk for RSV-associated lower respiratory tract disease are now eligible for the ...

Some respiratory viruses, especially RSV, are seeing a late winter to early spring surge in Wisconsin, public health experts ...

It’s a major cause of respiratory illness in all age groups, but young and old are at greatest risk.